19-11041427-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001387283.1(SMARCA4):c.4387C>G(p.Arg1463Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1463H) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4387C>G | p.Arg1463Gly | missense_variant | Exon 31 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.4291C>G | p.Arg1431Gly | missense_variant | Exon 30 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.4297C>G | p.Arg1433Gly | missense_variant | Exon 30 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.4201C>G | p.Arg1401Gly | missense_variant | Exon 30 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.4201C>G | p.Arg1401Gly | missense_variant | Exon 29 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.4201C>G | p.Arg1401Gly | missense_variant | Exon 29 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.4201C>G | p.Arg1401Gly | missense_variant | Exon 30 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.3712C>G | p.Arg1238Gly | missense_variant | Exon 27 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.2944C>G | p.Arg982Gly | missense_variant | Exon 23 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.2926C>G | p.Arg976Gly | missense_variant | Exon 22 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.2785C>G | p.Arg929Gly | missense_variant | Exon 22 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.2653C>G | p.Arg885Gly | missense_variant | Exon 21 of 25 | ENSP00000494159.1 | ||||
| SMARCA4 | ENST00000538456.4 | c.457C>G | p.Arg153Gly | missense_variant | Exon 4 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). ClinVar contains an entry for this variant (Variation ID: 824850). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 1463 of the SMARCA4 protein (p.Arg1463Gly). -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R1463G variant (also known as c.4387C>G), located in coding exon 30 of the SMARCA4 gene, results from a C to G substitution at nucleotide position 4387. The arginine at codon 1463 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at